Brimonidine tartrate is a relatively selective alpha-2 adrenergic agonist; the drug has the action of lowering intraocular pressure with minimal effect on cardiovascular and pulmonary parameters.
Indications
For lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.